Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Copper Catalyzed Radical Addition. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110256496B reveals a mild copper-catalyzed route to beta-thioindolones, offering safer alternatives to toxic CS2 methods for reliable pharmaceutical intermediate supply chains.
Patent CN110218229B reveals a mild copper-catalyzed route for beta-mercapto azaphospho derivatives, offering safer manufacturing and cost reduction for pharmaceutical intermediates.